| For: | De Wilde N, Vonghia L, Francque S, De Somer T, Bagdadi A, Staub E, Lambrechts J, Bucalau AM, Verset G, Van Steenkiste C. Real-life multi-center retrospective analysis on nivolumab in difficult-to-treat patients with advanced hepatocellular carcinoma. World J Hepatol 2022; 14(8): 1608-1620 [PMID: 36157862 DOI: 10.4254/wjh.v14.i8.1608] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i8/1608.htm |
| Number | Citing Articles |
| 1 |
Joanna Głowska-Ciemny, Marcin Szymański, Agata Kuszerska, Zbyszko Malewski, Constantin von Kaisenberg, Rafał Kocyłowski. The Role of Alpha-Fetoprotein (AFP) in Contemporary Oncology: The Path from a Diagnostic Biomarker to an Anticancer Drug. International Journal of Molecular Sciences 2023; 24(3): 2539 doi: 10.3390/ijms24032539
|
| 2 |
Fernand Bteich, Kush Desai, Chenxin Zhang, Anahat Kaur, Rachel Levy, Lydia Bioh, Aaron Wang, Sharmin Sultana, Andreas Kaubisch, Milan Kinkhabwala, Sarah Bellemare, Shabnam Fidvi, Devaraju Kanmaniraja, Robert Berkenblit, Jee-Young Moon, Adebola Adedimeji, Clara Tow, Yvonne Saenger. Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma in a Diverse and Underserved Population in the United States. Journal of Hepatocellular Carcinoma 2024; : 257 doi: 10.2147/JHC.S436804
|
| 3 |
Jie Tang, Hao Luo, Dongyun Hang, Qingyu Wang, Di Jin, Ming Xu, Liya Xu. The role of long noncoding RNA myocardial infarction-associated transcript in hepatocellular carcinoma: Targeting miR-361-3p to regulate cell proliferation, invasion, and apoptosis. Medicine 2026; 105(13): e47863 doi: 10.1097/MD.0000000000047863
|
| 4 |
Shalini Bansal, Priya Amin, Courtney Williamson, Stephen J. Valerio, David E. Kaplan. Outcomes with Single Tremelimumab Regular Interval Durvalumab (STRIDE) for Unresectable Hepatocellular Carcinoma in the US Veterans Administration. Cancers 2026; 18(7): 1085 doi: 10.3390/cancers18071085
|